Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Jun-30-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Revenues |
| Americas | 1,564.0 | 1,494.0 | 1,626.0 | 1,755.0 | 1,727.0 | 1,624.0 | 1,560.0 | 1,681.0 |
| EMEA | 762.0 | 738.0 | 699.0 | 1,252.0 | 779.0 | 783.0 | 738.0 | 1,052.0 |
| APAC | 638.0 | 647.0 | 627.0 | 744.0 | 720.0 | 691.0 | 648.0 | 700.0 |
| Medication Delivery | 761.0 | 710.0 | 706.0 | 784.0 | 747.0 | 697.0 | 652.0 | 743.0 |
| Other | 22.0 | 44.0 | 32.0 | 30.0 | 25.0 | 27.0 | 27.0 | 25.0 |
| |
| EBITDA |
| Americas | 498.0 | 488.0 | 610.0 | 705.0 | 676.0 | 632.0 | 599.0 | 663.0 |
| EMEA | 112.0 | 169.0 | 119.0 | 171.0 | 167.0 | 159.0 | 135.0 | 159.0 |
| APAC | 118.0 | 156.0 | 151.0 | 167.0 | 166.0 | 152.0 | 138.0 | 159.0 |
| |
| EBIT |
| Americas | 498.0 | 488.0 | 610.0 | 705.0 | 676.0 | 632.0 | 599.0 | 663.0 |
| EMEA | 112.0 | 169.0 | 119.0 | 171.0 | 167.0 | 159.0 | 135.0 | 159.0 |
| APAC | 118.0 | 156.0 | 151.0 | 167.0 | 166.0 | 152.0 | 138.0 | 159.0 |
| |
| Mix |
| Americas | 42.2% | 41.6% | 43.9% | 49.9% | 53.5% | 52.4% | 53.0% | 52.8% |
| EMEA | 20.6% | 20.5% | 18.9% | 35.6% | 24.1% | 25.3% | 25.1% | 33.1% |
| APAC | 17.2% | 18.0% | 16.9% | 21.2% | 22.3% | 22.3% | 22.0% | 22.0% |
| Medication Delivery | 20.5% | 19.8% | 19.0% | 22.3% | 23.2% | 22.5% | 22.1% | 23.4% |
| Other | 0.6% | 1.2% | 0.9% | 0.9% | 0.8% | 0.9% | 0.9% | 0.8% |
| |
| Growth |
| Americas | 4.7% | -8.0% | 4.2% | 4.4% | 7.5% | 10.6% | 4.1% | -8.8% |
| EMEA | 3.3% | -5.7% | -5.3% | 19.0% | 8.2% | 17.0% | -2.1% | 33.3% |
| APAC | -1.4% | -6.4% | -3.2% | 6.3% | 11.5% | 19.1% | 18.0% | 13.3% |
| Medication Delivery | 7.2% | 1.9% | 8.3% | 5.5% | 12.3% | 15.2% | -5.5% | 3.9% |
| Other | -50.0% | 63.0% | 18.5% | 20.0% | -3.8% | 0.0% | -76.5% | -110.3% |
|